Critical illness myopathy: Sepsis-mediated failure of the peripheral nervous system

European Journal of Anaesthesiology

Volumn 25, Issue SUPPL. 42, 2008, Pages 73-82

  Friedrich, O ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Critical care; Mucular diseases; Myopathy; Neuromuscular diseases; Polyneuropathy; Sepsis

Indexed keywords

VOLTAGE GATED SODIUM CHANNEL; CYTOKINE; SODIUM;

CLINICAL FEATURE; CRITICAL ILLNESS; EXCITATION CONTRACTION COUPLING; HUMAN; INTENSIVE CARE; MYOPATHY; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BIOPHYSICS; BIOPSY; CHEMISTRY; ELECTROPHYSIOLOGY; INFLAMMATION; METABOLISM; METHODOLOGY; MUSCLE; MUSCLE DISEASE; NEUROMUSCULAR DISEASE; PATHOLOGY;

ANIMALS; BIOPHYSICS; BIOPSY; CRITICAL ILLNESS; CYTOKINES; ELECTROPHYSIOLOGY; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MUSCLES; MUSCULAR DISEASES; NEUROMUSCULAR DISEASES; SEPSIS; SODIUM;

EID: 43149087799     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507003262     Document Type: Review

References (66)

1. Laupland KB. Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Critical Care 2004; 8: R431-R436.
2. Martin CM, Hill AD, Burns K, Chen LM. Characteristics and outcomes for critically ill patients with prolonged intensive care unit stays. Crit Care Med 2005; 33: 1922-1927.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Garcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
4. Brunkhorst FM, Engel C, Reinhart K et al. Epidemiology of severe sepsis and septic shock in Germany: results from the German 'Prevalence' study. Critical Care 2005; 9: P196.
5. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 2001; 248: 929-934.
6. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005; 32: 140-163.
7. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993; 33: 94-100.
8. Pastores SM. Critical illness polyneuropathy and myopathy in acute respiratory distress syndrome: more common than we realize! Crit Care Med 2005; 33: 895-896.
9. Zochodne DW, Bolton CF, Wells GA et al. Critical illness polyneuropathy: a complication of sepsis and multiple organ failure. Brain 1987; 110: 819-841.
10. Latronico N, Fenzi F, Recupero D et al. Critical illness myopathy and neuropathy. Lancet 1996; 347: 1579-1582.
11. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005; 11: 126-132.
12. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006; 67: 1421-1425.
13. Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Crit Care Med 2003; 29: 1505-1514.
14. Latronico N. Neuromuscular alterations in critically ill patients: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med 2003; 29: 1411-1413.
15. Friedrich O. Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 2006; 9: 403-409.
16. De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 2004; 30: 1117-1121.
17. Zarzhevsky N, Menashe O, Carmeli E, Stein H, Reznick AZ. Capacity for recovery and possible mechanism in immobilisation atrophy of young and old animals. Ann NY Acad Sci 2001; 928: 212-225.
18. Widrick JJ, Norenberg KM, Romantowski JG et al. Force velocity power and force-pCa relationships of human soleus fibres after 17 days of bed rest. J Appl Physiol 1998; 85: 1949-1956.
19. Ginz HF, Iaizzo PA, Girard T, Urwyler A, Parrger H. Decreased isometric skeletal muscle force in critically ill patients. Swiss Med Wkly 2005; 135: 555-561.
20. Eikermann M, Koch G, Gerwig M et al. Muscle force and fatigue in patients with sepsis and multiorgan failure. Intensive Care Med 2006; 32: 251-259.
21. Diaz NL, Finol HJ, Torres SH, Zambrano CI, Adjounian H. Histochemical and ultrastructural study of skeletal muscle in patients with sepsis and multiple organ failure syndrome (MOFS). Histol Histopathol 1998; 13: 121-128.
22. Reardon KA, Davis J, Kapsa RM, Choong P, Byrne E. Myostatin, insulin-like growth factor-1 and leukimia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 2001; 24: 893-899.
23. Machida S, Booth FW. Changes in signalling molecule levels in 10-day hindlimb immobilized rat muscles. Acta Physiol Scand 2005; 183: 171-179.
24. Caruso P, Denari SD, Ruiz SA et al. Inspiratory muscle training is ineffective in mechanically ventilated critically ill patients. Clinics 2005; 60: 479-484.
25. De Letter MA, van Doorn PA, Savelkoul HF et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 2000; 106: 206-213.
26. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997; 20: 665-673.
27. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24: 1408-1416.
28. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with veuronium during steroid treatment. Muscle Nerve 1991; 14: 1131-1139.
29. Hasselgren PO, Fischer JE. Sepsis: stimulation of energy-dependent protein breakdown resulting in protein loss in skeletal muscle. World J Surg 1998; 22: 203-208.
30. Norman H, Kandala K, Kolluri R et al. A porcine model of acute quadriplegic myopathy: a feasibility study. Acta Anaesthesiol Scand 2006; 50: 1058-1067.
31. De Jonghe B, Sharshar T, Lefaucheur JP et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-2867.
32. Berchtold MW, Brinkmeier H, Müntener M. Calcium ions in skeletal muscle: its crucial role for muscle function, plasticity and disease. Physiol Rev 2000; 80: 1215-1265.
33. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev 2000; 80: 853-924.
34. Murray MJ, Brull SJ, Bolton CF. Brief review: non-depolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anesth 2006; 53: 1148-1156.
35. De Letter MA, Schmitz PI, Visser LH et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001; 29: 2281-2286.
36. Hughes BJ, Krieg M. Increased glucocorticoid/androgen receptor ratios in denervated striated muscle. J Steroid Biochem 1986; 25: 695-699.
37. Rich MM, Kraner SD, Barchi SL. Altered gene expression in steroid-treated denervated muscle. Neurobiol Dis 1999; 6: 515-522.
38. Prigent H, Maxime V, Annane D. Clinical review: corticotherapy in sepsis. Crit Care 2004; 8: 122-129.
39. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998; 43: 171-179.
40. Rich MM, Pinter MJ. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001; 50: 26-33.
41. Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003; 547.2: 555-566.
42. v1.5 in a rat model of critical illness myopathy. J Physiol 2004; 559.3: 813-820.
43. Trunkey DD, Illner H, Wagner IY, Shires GT. The effect of septic shock on skeletal muscle action potentials in the primate. Surgery 1979; 85: 638-643.
44. Gibson WH, Cook JJ, Gatipon G, Moses ME. Effect of endotoxin shock on skeletal muscle cell membrane potential. Surgery 1977; 81: 571-577.
45. Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT. Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 1986; 164: 1368-1373.
46. Friedrich O, Hund E, Weber C, Hacke W, Fink RHA. Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J Neurol 2004; 251: 53-65.
47. Niiya T, Narimatsu E, Namiki A. Acute late sepsis attenuates effects of a non-depolarizing neuromuscular blocker, Rocuronium, by facilitation of endplate potential and enhancement of membrane excitability in vitro. Anesthesiology 2006; 105: 968-975.
48. Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. Clin Nutr 2004; 23: 273-280.
49. Williams AB, Decourten-Myers GM, Fischer JE, Luo G, Sun X, Hasselgren PO. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 1999; 13: 1435-1443.
50. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335: 1897-1905.
51. Laghi F, Tobin J. Disorders of the respiratory muscle. Am J Respir Crit Care Med 2003; 168: 10-48.
52. Solomon V, Goldberg AL. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996; 271: 26690-26697.
53. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α. FASEB J 1998; 12: 871-880.
54. Li YP, Reid MB. NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1165-R1170.
55. Acharrya S, Ladner KJ, Nelson LL et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114: 70-378.
56. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock and severe trauma. Crit Care Med 1997; 25: 1813-1819.
57. Price SR, England BK, Bailey JL, Van Vreede K, Mitch WE. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 1994; 267: C955-C960.
58. Horinouchi H, Kumamoto T, Kimura N, Ueyama H, Tsuda T. Myosin loss in denervated rat soleus muscle after dexamethasone treatment. Pathobiology 2005; 72: 108-116.
59. Fischer DR, Sun X, Prittis TA, Hasselgren PO. The amount of the glucocorticoid receptor (GR) and its hormone binding activity are increased in skeletal muscle during sepsis. Surg Forum 1999; 51: 214-216.
60. Combaret L, Taillandier D, Dardevet D et al. Glucocorticoids regulate mRNA levels for subunits of the 19S regulatory complex of the 26S proteasome in fast-twitch skeletal muscle. Biochem J 2004; 378: 239-246.
61. Lee MC, Wee GR, Kim JH. Apoptosis of skeletal muscle on steroid-induced myopathy in rats. J Nutr 2005; 135: 1806S-1808S.
62. Vanhorebeek I, Langouche L, van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006; 2: 20-31.
63. Vanhorebeek I, van den Berghe G. The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin 2006; 22: 1-15.
64. Riedemann NC, Guo RF, Ward PA. Novel strategies fort he treatment of sepsis. Nat Med 2003; 9: 517-524.
65. Brunkhorst FM, Kuhnt E, Engel C et al. Intensive insulin therapy in patients with severe sepsis and septic shock is associated with an increased rate of hypoglycemia - results from a randomized multicenter study (VISEP). Infection 2005; 33: 19-20.
66. Aghajani E, Nordhaug D, Korvald C et al. Mechanoenergetic inefficiency in the septic left ventricle is due to enhanced oxygen requirements for excitation-contraction coupling. Cardiovas Res 2004; 63: 256-263.